Scroll for more
Glioma MR Imaging 2.0
COST ACTION CA18206 Know more
Scroll for more
50 000 new cases of glioma per year in Europe PATIENTS Know more
Scroll for more
For initial diagnosis, treatment response assessment, and adverse effect monitoring GLIOMA MR IMAGING Know more
Scroll for more
Currently no open calls GRANTS Know more

Working Groups

In GliMR, we aim to achieve our goals by collaboration within and across five working groups:

WG1 – Advanced MRI biomarkers for glioma characterisation

Working Group 1 focusses on coordinating the identification and quantification of advanced MRI biomarkers for the application in the field of glioma.

WG2 – Multi-site data integration

Working Group 2 coordinates multi-site data integration and enables the creation of large datasets in glioma diagnostics via the creation of common GDPR- and BIDS-compliant forms and data structures.

WG3 – Clinical translation

Working Group 3 focusses on fostering cross-border information exchange about past and current clinical trials and studies of glioma.

WG4 – Stakeholder relations

Working Group 4 ensures representation of all relevant stakeholders within GliMR and acts as liason from GliMR to all relevant stakeholders.

WG5 – Dissemination

Working Group 5 disseminates the Action’s goals and results in tailored manners to all relevant stakeholders.

Members

Latest News

GliMR Live Stream at ESMRMB 2020

Congratulations to our Researcher of the Month: Jan Petr

List of the publications related to glioma imaging, published in July and August 2020

Latest Tweets